
AXENTRI 150 MG (1X60)
Product Description
AXENTRI 150 MG contains Enasidenib 150 mg, a targeted anticancer medicine used for certain adults with acute myeloid leukemia (AML) whose cancer cells have a specific IDH2 mutation. It belongs to a class of medicines called IDH2 inhibitors and works by blocking the abnormal IDH2 enzyme activity associated with IDH2-mutated cancer cells. AXENTRI may be prescribed for eligible patients according to their molecular test results and overall treatment plan. The medicine is generally taken orally once daily, with or without food, exactly as directed by an oncologist. Treatment requires regular medical monitoring because serious adverse reactions can occur, including differentiation syndrome and changes in liver function. Patients should report symptoms such as fever, unexplained weight gain, breathing difficulties, swelling, or reduced urine output promptly to their healthcare team. AXENTRI 150 MG (1X60) is a specialized prescription oncology product and should be supplied and used only in accordance with applicable medical, pharmaceutical, and import regulations.
Common Uses
Treatment of certain IDH2-mutated acute myeloid leukemia (AML)
Management of relapsed or refractory AML in eligible patients
Targeted therapy for AML with a confirmed IDH2 mutation
Treatment prescribed according to molecular diagnostic results
Oncology therapy under specialist supervision
20 Frequently Asked Questions
1. What is AXENTRI 150 MG?
AXENTRI 150 MG contains enasidenib, an IDH2-targeted anticancer medicine.
2. What is AXENTRI 150 MG used for?
It is used for certain adults with acute myeloid leukemia (AML) containing a susceptible IDH2 mutation.
3. What is the active ingredient in AXENTRI?
The active ingredient is enasidenib 150 mg.
4. How does AXENTRI work?
Enasidenib inhibits mutant IDH2 enzyme activity, helping target abnormal cellular processes associated with IDH2-mutated AML.
5. Is AXENTRI a chemotherapy medicine?
It is a targeted cancer therapy rather than a traditional cytotoxic chemotherapy medicine.
6. How is AXENTRI 150 MG taken?
It is taken orally according to the oncologist's prescribed treatment schedule. Follow the product leaflet and medical instructions carefully.
7. Can AXENTRI be taken with food?
Enasidenib can generally be taken with or without food, according to prescribing instructions.
8. What does 1X60 mean?
It generally indicates a pack containing 60 tablets, subject to the manufacturer's packaging configuration.
9. What is an IDH2 mutation?
An IDH2 mutation is a genetic change that can occur in certain cancer cells and may be identified through molecular diagnostic testing.
10. Does every AML patient need AXENTRI?
No. It is intended for specific patients whose disease has the appropriate IDH2 mutation and who meet the relevant treatment criteria.
11. What are common side effects of enasidenib?
Possible adverse effects include nausea, vomiting, diarrhea, decreased appetite, elevated bilirubin, and fatigue.
12. What is differentiation syndrome?
Differentiation syndrome is a potentially serious reaction associated with enasidenib treatment. Symptoms can include fever, weight gain, swelling, shortness of breath, and low blood pressure.
13. What should I do if symptoms of differentiation syndrome occur?
Contact the treating oncology team immediately if symptoms such as unexplained fever, rapid weight gain, swelling, breathing difficulty, or reduced urine output develop.
14. Can AXENTRI affect liver function?
Yes. Enasidenib can cause liver-related laboratory abnormalities, and appropriate monitoring may be required.
15. Can AXENTRI interact with other medicines?
Yes. It may interact with various medicines, including certain drugs metabolized by liver enzymes. Provide your oncologist with a complete medication and supplement list.
16. What should I do if I miss an AXENTRI dose?
Follow the prescribing instructions. Do not take extra doses to compensate unless specifically instructed by your oncology team.
17. Can AXENTRI be used during pregnancy?
Enasidenib may harm an unborn baby. Pregnancy prevention and appropriate medical counseling should be discussed with the treating healthcare professional.
18. Can AXENTRI be used while breastfeeding?
Breastfeeding is generally not recommended during treatment and for the specified period afterward. Follow your oncologist's advice.
19. Is AXENTRI 150 MG a prescription medicine?
Yes. It is a specialized prescription oncology medicine requiring appropriate medical supervision.
20. Is AXENTRI 150 MG available for international pharmaceutical supply?
International availability depends on destination-country regulations, oncology prescription requirements, import authorization, and product registration. Pharmaceutical sourcing should follow all applicable laws and regulations.
SEO Keywords
AXENTRI 150 MG supplier from India
AXENTRI 150 MG 1X60 exporter
Enasidenib 150 MG pharmaceutical supplier
AXENTRI oncology medicine exporter India
Enasidenib tablets supplier India
AXENTRI 150 MG wholesale pharmaceutical supplier
IDH2 inhibitor medicine supplier
AML targeted therapy pharmaceutical exporter
AXENTRI B2B medicine supplier India
Enasidenib oncology drug exporter
AXENTRI supplier USA New York
Enasidenib pharmaceutical exporter USA
AML medicine supplier USA
AXENTRI UK supplier Birmingham
Enasidenib medicine exporter UK
AXENTRI Canada supplier Toronto
oncology medicine exporter Canada
AXENTRI Australia supplier Adelaide
Enasidenib supplier Australia
AXENTRI Singapore supplier Orchard
oncology pharmaceutical exporter Singapore
AXENTRI South Korea supplier
Enasidenib medicine exporter South Korea
India to USA oncology medicine supplier
India to UK Enasidenib exporter
India to Canada cancer medicine supplier
India to Australia oncology exporter
India to Singapore pharmaceutical supplier
India to South Korea Enasidenib exporter
international Enasidenib B2B supplier
global AML targeted medicine exporter
Phoenix Exim AXENTRI supplier
Phoenix Exim oncology pharmaceutical exporter India
Keywords







